A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging.
Aki MorikawaMilan GrkovskiSujata PatilKomal L JhaveriKendrick TangJohn L HummAndrei HolodnyKathryn BealHeiko SchöderAndrew D SeidmanPublished in: Breast cancer research and treatment (2021)
Trial registration numbers and dates: NCT01724606 (November 12, 2012) and NCT01621906 (June 18, 2012).
Keyphrases
- brain metastases
- small cell lung cancer
- phase iii
- study protocol
- resting state
- white matter
- phase ii
- clinical trial
- acute myeloid leukemia
- early stage
- high resolution
- functional connectivity
- computed tomography
- cerebral ischemia
- randomized controlled trial
- open label
- pet ct
- squamous cell carcinoma
- brain injury
- radiation induced
- photodynamic therapy
- subarachnoid hemorrhage
- young adults